Body Mass Index and New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction

References

• Tedrow UB, Conen D, Ridker PM, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol. 2010;55(21):2319–2327. doi:10.1016/j.jacc.2010.02.029
   PubMed Web of Science ®Google Scholar
• Waldo AL. A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need. Am Heart J. 2006;151(4):771–778. doi:10.1016/j.ahj.2005.06.014
   PubMed Web of Science ®Google Scholar
• Aune D, Sen A, Schlesinger S, et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(3):181–192. doi:10.1007/s10654-017-0232-4
   PubMed Web of Science ®Google Scholar
• Singleton MJ, German CA, Soliman EZ, et al. Body mass index, sex, and incident atrial fibrillation in diabetes: the ACCORD trial. JACC Clin Electrophysiol. 2020;6(13):1713–1720. doi:10.1016/j.jacep.2020.08.008
   PubMedGoogle Scholar
• Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789–795. doi:10.1016/S0735-1097(01)01448-6
   PubMed Web of Science ®Google Scholar
• Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39(4):578–584. doi:10.1016/S0735-1097(01)01802-2
   PubMed Web of Science ®Google Scholar
• Angerås O, Albertsson P, Karason K, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2013;34(5):345–353. doi:10.1093/eurheartj/ehs217
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Report of a WHO consultation. Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser. 2000;894:i–xii, 1–253.
   PubMed Web of Science ®Google Scholar
• NHLBI Obesity Education Initiative. The practical guide identification, evaluation, and treatment of overweight and obesity in adults. Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/prctgd_c.pdf. Accesed June 15, 2022.
   Google Scholar
• Lavie CJ, De Schutter A, Parto P, et al. Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated. Prog Cardiovasc Dis. 2016;58(5):537–547. doi:10.1016/j.pcad.2016.01.008
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Arena R, Alpert MA, Milani RV, Ventura HO. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol. 2018;15(1):45–56. doi:10.1038/nrcardio.2017.108
   PubMed Web of Science ®Google Scholar
• Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031–2041. doi:10.1152/ajpheart.01058.2004
   PubMed Web of Science ®Google Scholar
• Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obes Facts. 2015;8(6):402–424. doi:10.1159/000442721
   PubMed Web of Science ®Google Scholar
• Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471–2477. doi:10.1001/jama.292.20.2471
   PubMed Web of Science ®Google Scholar
• Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity–results of a meta-analysis. Am Heart J. 2008;155(2):310–315. doi:10.1016/j.ahj.2007.10.004
   PubMed Web of Science ®Google Scholar
• Park SJ, Ha KH, Kim DJ. Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study. Cardiovasc Diabetol. 2020;19(1):191. doi:10.1186/s12933-020-01170-w
   PubMed Web of Science ®Google Scholar
• Jong CB, Li HY, Pan SL, et al. Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome. J Am Heart Assoc. 2019;8(7):e011215. doi:10.1161/JAHA.118.011215
   PubMed Web of Science ®Google Scholar
• Lancefield T, Clark DJ, Andrianopoulos N, et al. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv. 2010;3(6):660–668. doi:10.1016/j.jcin.2010.03.018
   PubMed Web of Science ®Google Scholar
• Emre E, Ural E, Aktas M, et al. The existence of obesity paradox and effect of obesity on in-hospital-outcomes on elderly patients treated with primary percutaneous coronary intervention. Int J Gerontol. 2018;12(1):17–21. doi:10.1016/j.ijge.2017.07.008
   Web of Science ®Google Scholar
• Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res. 2009;81(2):370–380. doi:10.1093/cvr/cvn288
   PubMed Web of Science ®Google Scholar
• Maguy A, Hebert TE, Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res. 2006;69(4):798–807. doi:10.1016/j.cardiores.2005.11.013
   PubMed Web of Science ®Google Scholar
• Dart C. SYMPOSIUM REVIEW: lipid microdomains and the regulation of ion channel function. J Physiol. 2010;588(17):3169–3178. doi:10.1113/jphysiol.2010.191585
   PubMed Web of Science ®Google Scholar
• Hissa B, Oakes PW, Pontes B, Ramírez-san juan G, Gardel ML. Cholesterol depletion impairs contractile machinery in neonatal rat cardiomyocytes. Sci Rep. 2017;7:43764. doi:10.1038/srep43764
   PubMed Web of Science ®Google Scholar
• Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120(10):863–870. doi:10.1016/j.amjmed.2007.05.011
   PubMed Web of Science ®Google Scholar
• De Schutter A, Lavie CJ, Arce K, Menendez SG, Milani RV. Correlation and discrepancies between obesity by body mass index and body fat in patients with coronary heart disease. J Cardiopulm Rehabil Prev. 2013;33(2):77–83. doi:10.1097/HCR.0b013e31828254fc
   PubMed Web of Science ®Google Scholar
• De Schutter A, Lavie CJ, Patel DA, Milani RV. Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr Opin Clin Nutr Metab Care. 2013;16(5):517–524. doi:10.1097/MCO.0b013e328363bcca
   PubMed Web of Science ®Google Scholar
• Baek YS, Yang PS, Kim TH, et al. Associations of abdominal obesity and new-onset atrial fibrillation in the general population. J Am Heart Assoc. 2017;6:6. doi:10.1161/JAHA.116.004705
   Web of Science ®Google Scholar
• Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120. doi:10.1186/s12933-017-0604-9
   PubMed Web of Science ®Google Scholar